Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare syndromic esophageal malformation characterized by severe congenital brachyesophagus with midline diaphragmatic hernia and secondary intrathoracic stomach, and vertebral anomalies (in particular rachischisis of the cervical/thoracic spine). Additional reported manifestations include intrauterine growth restriction, short neck, intestinal malrotation, herniation of other abdominal organs, and cleft lip, among others. The condition is mostly fatal in the neonatal or early infantile period.
Biomarker and diagnostic research for congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome.
202 publications have been identified in PubMed for congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome. Kisho has analyzed 87 by research type. Research spans Review / Meta-Analysis (56%), Case Report / Case Series (21%), and Basic Science / Preclinical (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 49 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:37 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome
Patient case studies | 18 | 21% |
Laboratory research | 10 | 11% |
Disease patterns and progression | 9 | 10% |
Testing and diagnosis research | 1 | 1% |
Hinkley JR (2026). [PMID: 32491636](https://pubmed.ncbi.nlm.nih.gov/32491636/). *Unknown Journal*. [Case Report / Case Series]
Chopra A (2026). [PMID: 41870099](https://pubmed.ncbi.nlm.nih.gov/41870099/). *Int Ophthalmol Clin*. [Review / Meta-Analysis]
Elsherbini A (2026). [PMID: 41689580](https://pubmed.ncbi.nlm.nih.gov/41689580/). *J Hand Surg Am*. [Review / Meta-Analysis]
Palaparthi S (2026). [PMID: 42091310](https://pubmed.ncbi.nlm.nih.gov/42091310/). *Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu*. [Review / Meta-Analysis]
Tkemladze T (2026). [PMID: 41044236](https://pubmed.ncbi.nlm.nih.gov/41044236/). *Eur J Hum Genet*. [Diagnostic / Biomarker]
Mokhtari A (2026). [PMID: 40842263](https://pubmed.ncbi.nlm.nih.gov/40842263/). *Clin Genet*. [Basic Science / Preclinical]
Tana C (2026). [PMID: 41980458](https://pubmed.ncbi.nlm.nih.gov/41980458/). *J Fr Ophtalmol*. [Review / Meta-Analysis]
Asagai Y (2025). [PMID: 40658219](https://pubmed.ncbi.nlm.nih.gov/40658219/). *Pediatr Nephrol*. [Case Report / Case Series]
Biglari S (2025). [PMID: 40101970](https://pubmed.ncbi.nlm.nih.gov/40101970/). *J Med Genet*. [Basic Science / Preclinical]
So N (2025). [PMID: 39992008](https://pubmed.ncbi.nlm.nih.gov/39992008/). *Australas J Dermatol*. [Review / Meta-Analysis]